Global News

Report: API market size worth $239.8B by 2025

Tuesday, January 24, 2017

The global active pharmaceutical ingredients (API) market is expected to reach a value of $239.8 billion by 2025, based on a new report by Grand View Research. The rising prevalence of lifestyle-induced & age-related diseases and cancer is projected to drive the market over the forecast period. Advancements in recombinant molecular technologies and high capitalization for development of novel drugs are also estimated to boost growth. 

[Read More]

PhRMA launches media initiative

Tuesday, January 24, 2017

The Pharmaceutical Research and Manufacturers of America (PhRMA) has launched a national, multi-year advertising and public affairs initiative on behalf of America’s biopharmaceutical companies. The campaign, GOBOLDLY, will showcase the industry’s unsung heroes driving cutting-edge advances in science and highlight the tremendous opportunity that exists to tackle our most complex and devastating health conditions. 

[Read More]

Accelsiors expands global footprint

Tuesday, January 24, 2017

Accelsiors has announced the opening of a new office in Gurgaon, India. This investment will provide our biotechnology, pharmaceutical and medical device customers with greater access to patient populations in an increasingly well-regulated environment.

[Read More]

Chan Zuckerberg Initiative to acquire AI startup Meta

Tuesday, January 24, 2017

iGan Partners is thrilled to announce the pending acquisition of its portfolio company, Meta, by the Chan Zuckerberg Initiative. Launched in 2015 by Mark Zuckerberg and Dr. Priscilla Chan, the Chan Zuckerberg Initiative is dedicated to advancing human potential and promoting equal opportunity, with a current focus on scientific research, education, and building strong communities. The goal of their science initiative is to cure, prevent, or manage all diseases by the end of this century.

[Read More]

Acutus Medical named a “Fierce 15” Medical Device Companies of 2016

Monday, January 23, 2017

Acutus Medical has been named by FierceMedicalDevices as one of 2016’s Fierce 15 med tech companies, designating it as one of the most promising private med tech companies in the industry. Acutus Medical is a company committed to transforming the lives of millions of patients by providing electrophysiologists (EPs) a highly unique, dual platform portfolio of breakthrough products that image, diagnose and treat complex arrhythmias.

[Read More]

Bioclinica hires Kraus, Zaim, Levy assume key roles

Monday, January 23, 2017

Bioclinica, a provider of specialized science and technology-enabled services supporting clinical trials, has announced three executive additions to its global Medical Imaging & Biomarkers leadership team. With global headquarters in Princeton, New Jersey, Bioclinica’s Medical Imaging & Biomarkers business segment is the world clinical trial leader in medical imaging, providing cardiac safety monitoring services, specialized biochemical marker analysis, and clinical lab services in the Bioclinica molecular marker laboratory. Joining Bioclinica are Andrew Kraus, chief operating officer; Souhil Zaim, M.D., head of Global Medical and Science Affairs; and Sara Levy, vice president, Client Services. All three will report to David Herron, president, Medical Imaging & Biomarkers.

[Read More]